Delivery Order SPE2DB22D9239-SPE2DB24FDE37
- Not listed
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at four thousand three hundred eleven dollars and thirty-five cents ($4,311.35) by the Defense Logistics Agency to supply one hundred twenty (120) capsules of XTANDI 40 MG CAPSULE. The delivery order was awarded on November 28, 2023 under DMS Pharmaceutical Group's indefinite delivery contract with the Defense Logistics Agency to provide pharmaceutical supplies with a potential value of up to five million...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at $4,311.35 by the Defense Logistics Agency to supply 120 capsules of XTANDI 40 MG CAPSULE. The delivery order was issued against DMS Pharmaceutical Group's indefinite delivery contract with the Defense Logistics Agency to provide pharmaceutical supplies with a potential value of up to $5 million through December 2025. As a woman-owned small business, DMS Pharmaceutical Group will deliver the...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order against its indefinite delivery contract with the Defense Logistics Agency to supply XTANDI 40 MG CAPSULE 120S. The $8,622.72 order has a completion date of November 24, 2023 and was awarded on November 22, 2023. DMS Pharmaceutical Group holds this indefinite delivery contract with the Defense Logistics Agency to provide pharmaceutical supplies with a potential value of up to $5 million through December 2025. As a...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at four thousand one hundred sixty-nine dollars and fifty-nine cents ($4,169.59) by the Defense Logistics Agency Troop Support Medical to provide sixty tablets of XTANDI 80 MG each. The delivery order was awarded on December 4, 2023 under DMS Pharmaceutical Group's indefinite delivery contract with the Defense Logistics Agency to supply pharmaceuticals and medical products with a potential value of up to five...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order against its indefinite delivery contract with the Defense Logistics Agency to provide XTANDI 40 MG CAPSULE 120S. The $12,934.05 order has a completion date of December 5, 2023 and was awarded on December 4, 2023. DMS Pharmaceutical Group holds this indefinite delivery contract with the Defense Logistics Agency to supply various pharmaceutical items and medical supplies with a potential value of up to $5 million...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed-price Delivery Order valued at $8,622.72 to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of XTANDI 40 MG CAPSULE 120S. This order is placed against DMS Pharmaceutical Group's indefinite delivery contract 4600082013 with the Defense Logistics Agency, valued at up to $4,999,999 through 2025, to provide a broad range of pharmaceutical items to military health facilities worldwide. DMS...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at four thousand one hundred sixty-nine dollars and fifty-nine cents ($4,169.59) by the Defense Logistics Agency Troop Support Medical to provide one hundred twenty (120) tablets of XTANDI 40 MG. The delivery order was issued against DMS Pharmaceutical Group's indefinite delivery contract with the Defense Logistics Agency to supply pharmaceuticals and medical products with a potential value of up to five...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at four thousand one hundred sixty-nine dollars and fifty-nine cents ($4,169.59) by the Defense Logistics Agency Troop Support Medical to provide one hundred twenty (120) XTANDI 40 MG tablets. The delivery order was awarded on December 6, 2023 under DMS Pharmaceutical Group's indefinite delivery contract with the Defense Logistics Agency to supply pharmaceuticals and medical products with a potential value of...
- The U.S. Defense Logistics Agency awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide 120 capsules of the pharmaceutical product XTANDI 40 MG. The $8,622.72 order has a completion date of January 17, 2024. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that holds various federal contracts to supply pharmaceuticals and medical products to support military treatment facilities worldwide. This delivery order is issued...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order against its indefinite delivery contract with the Defense Logistics Agency to supply XTANDI 40 MG CAPSULE 120S. The $8,622.72 order has a completion date of November 3, 2023 and was awarded on November 2, 2023. No set-aside designation was used for this order placed by the Defense Logistics Agency Troop Support Medical to fulfill pharmaceutical needs at its facilities located in Park Ridge, Illinois. DMS...
- SPE2DB22D9239Indefinite Delivery Contract
- SPE2DB22D9239-SPE2DB24FDE37Delivery Order
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at twenty-five thousand, eight hundred sixty-eight dollars and ten cents ($25,868.10) by the Defense Logistics Agency to supply one hundred twenty (120) capsules of XTANDI 40 MG CAPSULE. The delivery order was awarded on November 15, 2023 under DMS Pharmaceutical Group's indefinite delivery contract with the Defense Logistics Agency to provide pharmaceutical supplies with a potential value of up to five million dollars ($5,000,000) through December 2025. No set-aside designation was used for this particular award. DMS Pharmaceutical Group will fulfill the delivery order as a woman-owned small business by the specified completion date of November 16, 2023. The delivery order supports the Defense Logistics Agency's provision of pharmaceuticals and medical products to military treatment facilities worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $25.9k | 11/15/23 |